SCHEMBL23493002

SCHEMBL23493002

CC(CNCC(=O)NCC(=O)OCc1ccccc1)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BCHE P06276 2/20 0.47
▸ CYP1A2 P05177 1/20 0.46
▸ CYP3A4 P08684 1/20 0.46
▸ CYP2D6 P10635 1/20 0.46
▸ CYP2C9 P11712 1/20 0.46
▸ CYP2C19 P33261 1/20 0.46
▸ ABCC3 O15438 1/20 0.46
▸ NR1I2 O75469 1/20 0.46
▸ ABCB11 O95342 1/20 0.46
▸ NR3C1 P04150 1/20 0.46
▸ RARG P13631 1/20 0.46
▸ CNR1 P21554 1/20 0.46
▸ OPRK1 P41145 1/20 0.46
▸ NR1H2 P55055 1/20 0.46
▸ PPARA Q07869 1/20 0.46
▸ NR1H3 Q13133 1/20 0.46
▸ NR1I3 Q14994 1/20 0.46
▸ CRHBP P24387 1/20 0.46
▸ CRHR2 Q13324 1/20 0.46
▸ MAPT P10636 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23491900 0.85 CYP1A2 (0.52) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL23491352 0.81 NPC1 (0.48) RAB9AMEN1KMT2AALDH1A1L3MBTL1
SCHEMBL8050669 0.78 ALDH1A1 (0.53) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
Hydrochloric Acid SCHEMBL11684413 0.77 ALDH1A1 (0.51) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL13073758 0.77 LMNA (0.55) RAB9AMEN1KMT2A
SCHEMBL13073762 0.77 LMNA (0.55) RAB9AMEN1KMT2A
SCHEMBL23491692 0.77 MEN1 (0.49) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL9112878 0.77 CYP1A2 (0.54) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL13296294 0.77 KMT2A (0.56) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL19844612 0.76 CYP2D6 (0.61) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021113682-A1 MASP-2 INHIBITORS AND METHODS OF USE OMEROS CORPORATION (US) 2021-06-10 — — WO disclosed
Send feedback